I-MAB - stock earnings
IMAB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -15.4 million USD | 391403 USD |
| 2023Q1 | -434.0 million USD | -257.2 million USD |
| 2022Q2 | -523.4 million CNY | 25.9 million CNY |
| 2022Q1 | -302.9 million USD | -238.3 million USD |
| 2021Q4 | -627.5 million CNY | 35.1 million CNY |
| 2021Q3 | -627.5 million CNY | 35.1 million CNY |
| 2021Q2 | -538.2 million CNY | 8.9 million CNY |
| 2021Q1 | 158.9 million USD | 235.4 million USD |
| 2020Q4 | -59.0 million USD | 236.1 million USD |
| 2020Q3 | -56.7 million USD | ? USD |
| 2020Q2 | -82.5 million USD | ? USD |
| 2020Q1 | -49.1 million USD | ? USD |
| 2019Q4 | -50.0 million USD | 4.3 million USD |
| 2019Q3 | -34.6 million USD | 2.1 million USD |
| 2019Q2 | -124.8 million USD | 2.2 million USD |
| 2019Q1 | 0 USD | ? USD |
| 2018Q4 | -18.0 million USD | 1.5 million USD |
| 2018Q3 | -16.4 million USD | 3.2 million USD |
| 2018Q2 | ? USD | 484390 USD |
IMAB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -350.1 million USD | -32.2 million USD |
| 2021 | -366.9 million USD | 13.9 million USD |
| 2020 | 72.1 million USD | 236.1 million USD |
| 2019 | -208.5 million USD | 4.3 million USD |
| 2018 | -58.6 million USD | 7.8 million USD |
| 2017 | -45.7 million USD | 1.8 million USD |
IMAB
Price: $1.80
52 week price:
Earnings Per Share: -3.74 USD
P/E Ratio: -0.46
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 425462
Market Capitalization: 147.7 million